Greg Baker, CEO of AffirmedRx, discusses the DRUG Act legislation and its potential impact on curbing rising drug costs through PBM reform.
This episode of Pharmacy Focus: Policy Edition focuses on the DRUG Act and PBM reform efforts with Greg Baker, RPh, CEO of AffirmedRx. The DRUG Act aims to address unfair PBM practices like revenue-based compensation models that incentivize higher drug prices. Baker provides an overview of the key provisions in the legislation and their significance, and the implications of D-linking PBM compensation from drug list prices are also explored. Baker emphasizes the need for transparency in the PBM industry and advocates for fair pharmacist compensation.
0:00:33 - Overview of the Drug Act
0:02:42 - Implications of D-linking for PBMs
0:04:26 - Impact of D-linking on US drug spending
0:05:47 - Benefits of further congressional action for patients and pharmacies
0:08:36 - Other relevant legislation for pharmacists to watch
